Nova Steroid Pharma Co.,Ltd
Superior Quality CJC1295 Without DAC Peptides Powder For Bodybuilding CAS:863288-34-0

Superior Quality CJC1295 Without DAC Peptides Powder For Bodybuilding CAS:863288-34-0

When you peel back the aluminum flip‑top of a sterile 5mg or 10mg lyophilised powder vial labelled “CJC‑1295 (no DAC),” what exactly are you looking at? Contrary to what the name might suggest, it is not strictly un‑modified CJC‑1295. It is technically “Modified GRF 1‑29” — a 29‑amino‑acid synthetic peptide modelled after the first 29 residues of natural Growth Hormone Releasing Hormone, with four strategically substituted amino acids that render it significantly more resistant to rapid enzymatic breakdown in human serum. A user on an ExcelMale forum puts it plainly: “To be clear, what is considered normal CJC‑1295 without DAC is a misnamed Mod GRF”.

Send Inquiry
Description

    From Vial to Vein – Cracking Open the Powder Vial

    When you peel back the aluminum flip‑top of a sterile 5mg or 10mg lyophilised powder vial labelled "CJC‑1295 (no DAC)," what exactly are you looking at? Contrary to what the name might suggest, it is not strictly un‑modified CJC‑1295. It is technically "Modified GRF 1‑29" - a 29‑amino‑acid synthetic peptide modelled after the first 29 residues of natural Growth Hormone Releasing Hormone, with four strategically substituted amino acids that render it significantly more resistant to rapid enzymatic breakdown in human serum. A user on an ExcelMale forum puts it plainly: "To be clear, what is considered normal CJC‑1295 without DAC is a misnamed Mod GRF".

    The powder itself appears as a white, fluffy cake or pellet pressed against the bottom of the vial by the freeze‑drying process. It is, for all practical purposes, inert at this stage - no biological activity until it is reconstituted with bacteriostatic water. Its molecular architecture lacks the "drug affinity complex" appendage, meaning it does not bind covalently to serum albumin after injection. Therefore, once it enters subcutaneous tissue and diffuses into circulation, it carries an active half‑life of roughly 30 minutes.

    Why would any bodybuilding user deliberately choose such a short‑lived compound? That is the central, counter‑intuitive premise of "no DAC" and the reason this article exists. The short half‑life is not a defect; it is the feature that makes the peptide mimic the body's natural pulsatile growth hormone rhythm rather than forcing a flattened, unnatural GH "bleed."

beginners-guide-to-natural-bodybuildingad2cacd8-9366-41d0-b387-0a8e7d8449a5

bodybuilding

Features – Pulse Over Plateau

    The defining feature of CJC‑1295 without DAC is its transient receptor activation. Upon subcutaneous injection, it occupies GHRH receptors on the anterior pituitary for about half an hour, delivering a fast, discrete pulse of endogenous Growth Hormone into the bloodstream. From there, GH travels to the liver and triggers the production of Insulin‑Like Growth Factor 1 (IGF‑1) - the true driver of protein synthesis, nitrogen retention, and myofibrillar repair.

    A user report from an AnabolicMinds log captures this theme: "I prepare the 3 injections for the day, store in fridge … I take one dose with me to work … I will continue to use this for the rest of my life … ZERO bloat, ZERO hunger … this stuff sheds fat instead".

    Contrast this with the "DAC" variant (half‑life ~6‑8 days, sometimes up to two weeks). CJC‑1295 with DAC creates sustained GH elevation that unnaturally flattens the natural pulse amplitude, a phenomenon bodybuilding forums have labelled "GH bleed." A Reddit analogy: "The 'with DAC' version is basically a slow release formulation that helps to keep the medication in the therapeutic range for much longer periods". That sustained profile is desirable for certain clinical scenarios - wound healing or lipodystrophy - but for the gym athlete prioritising natural‑mimetic tissue repair and lean mass accrual, no‑DAC is overwhelmingly preferred among experienced users.

Mechanism in Plain Language

    You can understand CJC‑1295 without DAC as a light switch - it turns on GH secretion with a short, sharp flick, then turns off almost completely, allowing the natural inhibitory hormone somatostatin to reset the system for the next pulse. In contrast, CJC‑1295 with DAC acts more like a leaky tap - GH drips continuously, losing the signalling advantages of rhythmic secretion.

    For the bodybuilder, this matters because:

    ●Receptor sensitivity is preserved. Continuous GH signalling can desensitise the pituitary and reduce GH pulse amplitude over weeks. Pulsatile stimulation keeps the axis fresh.

    ●Endogenous feedback loops are not overwhelmed. No‑DAC works with the hypothalamus, not against it.

    ●Timing can be targeted. Shots placed around fasted training windows or pre‑sleep match natural GH surge periods.

Applications in the Real‑World Gym

    The core applications actually reported by active users, rather than speculated, include:

    ●Enhanced deep sleep architecture. This is overwhelmingly the first thing users notice, not muscle gain. Over and over, logs report "four weeks in and sleeping better was the first noticeable thing". Another user on Reddit: "After the first dose, I slept so well".

    ●Improved recovery from training microtrauma. Not immediate strength jumps, but reduced delayed‑onset muscle soreness, faster return to the gym, and better ability to sustain high volume.

    ●Subcutaneous fat mobilisation. Several logs specifically mention loss of lower‑belly and hip fat even without dramatic dietary changes, attributed to GH's lipolytic effect.

    ●Lean tissue preservation during cutting phases. When calories dip, the anabolic environment supported by elevated IGF‑1 helps hold onto muscle mass.

    ●Collagen synthesis and connective tissue resilience. Long‑term users report fewer nagging tendon issues.

    One important caveat: younger men with a still‑robust natural GH profile will notice less effect than older lifters. The older the user, the more dramatic the subjective outcome. A 52‑year‑old on a fitness forum recorded an IGF‑1 jump from 227 ng/mL to 406 ng/mL after eight weeks of three‑daily doses. That is a clinical elevation into young‑adult range.

Dosing and Timing – The "Three Shots" Economy

    The saturation dose for GHRH analogues is approximately 1 µg per kilogram of body weight. For an 80 kg (176 lb) user, that is roughly 80‑100 µg per injection. Higher doses - 200‑250 µg - do not double the GH output; they modestly increase the area under the curve but also accelerate cost and injection fatigue.

    The real decision is not how much per shot, but how many pulses per day. The three most common user‑driven protocols are:

    ●Single pre‑bed shot (fasted 2‑3 hours). Most practical for beginners. Aligns with the body's natural overnight GH surge.

    ●Morning and pre‑bed (two shots). Catches the AM cortisol‑associated GH release window plus the night pulse.

    ●Three shots (morning, mid‑afternoon or post‑training, pre‑bed). Gold standard for users seeking maximal IGF‑1 elevation. "100 mcg of each x 3 times a day … increased my IGF‑1 from 227 to 406".

    Most cycling logs adopt a 5‑days‑on / 2‑days‑off weekly pattern rather than continuous daily injection. This helps preserve receptor sensitivity over long use periods.

    Because the half‑life merely 30 minutes, every injection is effectively a fresh event. Missed shots are not cumulative; you simply lose that pulse.

Reconstitution and Storage – The Practical Manual

    For a 5 mg vial of lyophilised powder: add 2 mL of bacteriostatic water, swirl gently (do not shake; shaking denatures peptides), and refrigerate immediately. After reconstitution, one full insulin syringe (100 units) contains approximately 250 µg of peptide per 0.1 mL, depending on the arithmetic chosen. A user's practical note: "I prepare the 3 injections for the day, store in fridge in 3/10 syringes. I take one dose with me to work, and store in lunch in fridge".

    Critical rules often omitted from generic instructions:

    ●Draw both CJC and Ipamorelin into the same syringe. Users regularly combine them in one sub‑Q injection, reducing pin count. The peptides are compatible and synergistic.

    ●Do NOT eat 2‑3 hours before or 20‑30 minutes after injection. Food - specifically carbohydrates and fats - elevates insulin and blunts GH release from the pituitary. Empty stomach is mandatory.

    ●Use 29‑gauge 0.5‑inch insulin syringes. Subcutaneous administration into abdominal fat or love‑handle area minimises pain and scar tissue.

Cycle Length and Physiological Downtime

    A standard initial cycle runs 8 to 12 weeks. The user who logged 12 weeks of 100 µg three times daily reported consistent efficacy without decline, noting "never loses effectiveness like MK‑677". In contrast, GH secretagogues such as GHRP‑6 or MK‑677 often show tolerance after 4‑6 months; no‑DAC shows no such receptor downregulation over practical bodybuilding intervals.

    After 12‑16 weeks, users typically take 4‑6 weeks off the peptide entirely. This is not strictly "PCT" in the androgen sense (pituitary suppression does not occur with GHRH agonists to a clinically problematic degree, and normal GH production resumes naturally within days), but the break accomplishes two objectives:

    1.Resets any subtle receptor habituation that might blunt subjective response.

    2.Reduces injection burden and allows cost averaging over a longer yearly calendar.

    Some lifelong users simply run the 5‑on‑2‑off pattern without month-long breaks, reporting no loss of effect even years later.

Synergistic Stacking – The Unspoken Rule

    Almost nobody runs CJC‑1295 without DAC by itself. The reason is pharmacokinetic: GHRH analogues (CJC) work best when co‑administered with a GHS (Growth Hormone Secretagogue) such as Ipamorelin, GHRP‑2, or GHRP‑6. The GHRH component "primes" the pituitary while the GHS component suppresses somatostatin - the natural brake on GH release - creating a double‑stimulus effect that far exceeds either peptide alone.

    The stack of choice for most bodybuilders: CJC‑1295 no‑DAC + Ipamorelin (IPA). One forum participant summarises: "CJC‑1295 (without DAC) enhances your body's natural GHRH signalling. Ipamorelin acts as a highly selective growth hormone secretagogue … Together, they create a coordinated pulse that mimics your body's natural GH rhythm". Ipamorelin specifically is favoured over GHRP‑2 or GHRP‑6 because it does not spike cortisol or prolactin and produces none of the intense hunger sides.

    Dosage for the stack: equal amounts, usually 100‑150 µg of each per injection, drawn into the same insulin syringe.

Documented Benefits from User Logs
Benefit User Source / Report
Deeper sleep, vivid dreams "Four weeks in and sleeping better was the first noticeable thing"
Reduced lower‑belly fat "Fat loss was noticeable, especially around the lower belly"
Improved skin/joint quality "Collagen production for skin and joints"
Increased IGF‑1 from 227 to 406 ng/mL Lab‑confirmed 8‑week result on three‑daily dosing
Zero water bloat "ZERO bloat, ZERO hunger" - in contrast to MK‑677 bloat
Lean mass preservation during calorie restriction Anecdotally widespread in cutting logs
Side Effects and Risk Awareness – Not Harmless

    CJC‑1295 without DAC is not side‑effect‑free, despite being milder than synthetic HGH injections.

    ●Injection site reactions. Redness, itching, transient wheals - especially common when stacking with GHK‑Cu or other irritants.

    ●Flushing and mild tachycardia. Subcutaneous injection can cause temporary facial flushing and slightly elevated heart rate. A Reddit user noted "inconsistent flushing feeling … a flushed face feeling with only 100 mcg".

    ●Transient water retention in the first week. Most often around the hands and ankles; resolves after 7‑10 days.

    ●Increased hunger (if stacked with GHRP‑6 or GHRP‑2). Ipamorelin stack avoids this almost entirely.

    ●Potential endocrine disruption in adolescents. A cautionary user at age 17 reported "an endocrinologist … was concerned about my past use of peptides … while your growth plates are still open".

    ●Should be avoided or medically cleared before use in: active cancer (GH can theoretically promote tumour growth), uncontrolled diabetes (GH impairs insulin sensitivity), pregnancy/breastfeeding, and individuals with known hypersensitivity to any GHRH analogue.

Clinical Data

Trade names

CJC-1295 No DAC

CAS

863288-34-0

Molar mass

3367.954

Formula

C152H252N44O42

Purity

Above 98%

Apprarance

White crystalline powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

QQ20240306150406            product-948-1135                        product-521-245

 

Does This Require Post‑Cycle Therapy?

    No, not in the manner that anabolic‑androgenic steroids or SARMs require SERMs like Tamoxifen or Clomiphene. The hypothalamic‑pituitary‑somatotropic axis does not undergo suppressive shutdown from GHRH agonists because the feedback loop remains intact. GH levels normalise within 1‑3 days of cessation. However, "PCT" in the peptide community is informal - typically a month off after 12 weeks on, just to restore full receptor sensitivity and give the injection sites a break. No pharmacological intervention is required.

 

Hot Tags: superior quality cjc1295 without dac peptides powder for bodybuilding cas:863288-34-0, China superior quality cjc1295 without dac peptides powder for bodybuilding cas:863288-34-0 manufacturers, suppliers, factory

Inquiry
goTop

(0/10)

clearall